Richter Gedeon Vegyeszeti Gyar Nyrt

Richter Gedeon Vegyeszeti Gyar Nyrt

Health CarePharmaceuticals & Biotechnology
  • Price (HUF)8,620.00
  • Today's Change80.00 / 0.94%
  • Shares traded185.07k
  • 1 Year change+26.76%
  • Beta0.5805
Data delayed at least 15 minutes, as of Sep 23 2021 16:05 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Key statistics

On Thursday, Richter Gedeon Vegyeszeti Gyar Nyrt (RICHTER:BUD) closed at 8,620.00, -7.51% below its 52-week high of 9,320.00, set on Mar 31, 2021.
52-week range
6,280.00Oct 28 20209,320.00Mar 31 2021
Markit short selling activity
Previous close8,540.00
Average volume188.98k
Shares outstanding186.37m
Free float139.32m
P/E (TTM)16.02
Market cap1.59tn HUF
EPS (TTM)533.04
Annual div (ADY)225.32
Annual div yield (ADY)2.64%
Div ex-dateJun 04 2021
Div pay-dateJun 14 2021
Data delayed at least 15 minutes, as of Sep 23 2021 16:05 BST.
More ▼

Executive Board


Erik Bogsch, Chairman


Gabor Orban, Chief Executive Officer


Dr Gabor Gulacsi, Deputy Managing Director


Dr Istvan Greiner, Research Director


Tibor Horvath, Commercial Director


Dr Gyorgy Thaler, Development Director


Registered Office: Gedeon Richter Plc. Gyomroi ut 19-21. H-1103 Budapest Hungary

T: (36) 1-431-4000 F: (36) 1-260-6650

Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.